NEW YORK (Reuters) -Wells Fargo has agreed to pay a $35 million civil penalty to settle U.S. charges that the company overcharged advisory fees, the Securities and Exchange Commission (SEC) said on Fr[...]
Read moreAugust 25, 2023
U.S. consumer sentiment slips slightly in August
By Safiyah Riddle (Reuters) -U.S. consumer sentiment fell modestly in August, as short and long term inflation expectations worsened, a survey showed on Friday. The University of Michigan’s fina[...]
Read moreEricsson sees IPR licensing revenues of $1 billion this year
STOCKHOLM (Reuters) -Sweden’s Ericsson predicted on Friday intellectual property rights (IPR) licensing income of 11 billion Swedish crowns ($1 billion) this year after it renewed a patent cross[...]
Read moreIndian food delivery firm Swiggy restarts IPO plans, aims for 2024 listing- sources
By M. Sriram MUMBAI (Reuters) – Swiggy, the Softbank-backed food delivery company, is eyeing a 2024 stock market listing and has initiated talks with bankers to assess its valuation, after halti[...]
Read more3M settles US anti-bribery law charges in China unit, SEC says
(Reuters) – 3M Co has agreed to pay more than $6.5 million to resolve U.S. charges of Foreign Corrupt Practices Act violations (FCPA) related to a 3M subsidiary in China, the Securities and Exch[...]
Read moreFed’s Mester keeps door open for more rate hikes in CNBC interview
By Michael S. Derby NEW YORK (Reuters) – Federal Reserve Bank of Cleveland President Loretta Mester said on Friday it’s quite possible the central bank will raise rates again. “We pr[...]
Read moreRate hike chances rise after remarks by Fed’s Powell
By Gertrude Chavez-Dreyfuss and Dan Burns NEW YORK (Reuters) – Interest rate futures tied to the Federal Reserve’s policy rate on Friday priced in a more than even chance of tightening at[...]
Read moreAstraZeneca sues US over Medicare drug price negotiation plans
(Reuters) -AstraZeneca said on Friday it has sued the U.S. government to block parts of a program that gives the Medicare health insurance plan the power to negotiate lower drug prices. The British dr[...]
Read moreBofA sees “trouble” ahead for tech stocks despite big inflows
By Lewis Krauskopf and Yoruk Bahceli (Reuters) – Strategists at BofA Global Research see second-half “trouble” for technology stocks even as the sector took in its largest inflow in[...]
Read more